Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

- PMLiVE

Seattle Genetics makes case for Padcev plus Keytruda in first-line bladder cancer

Hopes to extend the antibody drug conjugate's use into the earlier setting

- PMLiVE

This isn’t goodbye, it’s see you in August!

Bedrock Group imagines, creates and delivers industry-leading benefits

Bedrock Healthcare Communications

- PMLiVE

Novartis plans inclisiran trial in the UK

Swiss pharma also officially opens new London headquarters

- PMLiVE

A market-adapted agile approach to launch excellence

By Suzie Denton

- PMLiVE

It started with a miss

Is pharma finally heading for launch excellence?

Courageous Conversations ep.2: What Our Healthcare System Can Learn from AlphaGo

Impetus Digital

Courageous Conversations ep.1: Why Our Healthcare System is in Dire Need of Disruption

Impetus Digital

- PMLiVE

FDA starts priority review of Kite’s CAR-T for mantle cell lymphoma

KTE-X19 is also under regulatory review with the EMA

Novartis day

Novartis pulls ahead of Merck in MET-positive lung cancer race

FDA starts priority review of Swiss pharma's MET inhibitor

- PMLiVE

Exelixis bounces back with new prostate cancer data

Announces encouraging results after initial trial fail

- PMLiVE

Botox strength bolsters Allergan ahead of AbbVie takeover

Speciality drugmaker posted a 6.6% sales increase in the last quarter

- PMLiVE

Onyx Health receive national recognition as a “one to watch” business in Newcastle

Specialist marketing communications agency Onyx Health have been nationally recognised by The Sunday Times as one of six “one to watch” businesses based in Newcastle.

Onyx Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links